Eberhard Karls Universität Tübingen

TP53 mutations in functional corticotroph tumors are linked to invasion and worse clinical outcome (2022) Perez-Rivas LG, Simon J, Albani A, Tang S, Roeber S, Assie G, Deutschbein T, et al. Journal article Genotyping-by-sequencing-based identification of Arabidopsis pattern recognition receptor RLP32 recognizing proteobacterial translation initiation factor IF1 (2022) Fan L, Fröhlich K, Melzer E, Pruitt RN, Albert I, Zhang L, Joe A, et al. Journal article Digital Mental Health - Breaking a Lance for Prevention (2022) Schuller BW, Lochner J, Qian K, Hu B Journal article Ingold, Tim. Correspondences. viii, 230 pp., bibliogr. Cambridge: Polity, 2020. £15.99 (paper)Taussig, Michael. Mastery of non‐mastery in the age of meltdown. 192 pp., illus., bibliogr. Chicago: Univ. Press, 2020. £20.00 (paper) (2022) Rivera Andía JJ Other publication type Human-machine-communication: introduction to the special issue (2022) Etzrodt K, Gentzel P, Utz S, Engesser S Journal article Efficacy of Ropeginterferon Alpha 2b in Inducing Treatment Free Remission in Chronic Myeloid Leukemia - an International, Randomized Phase III Trial (ENDURE, CML-IX) of the German CML-Study Group (2022) Burchert A, Saussele S, Michel C, Metzelder SK, Hochhaus A, Gattermann N, Crysandt M, et al. Conference contribution Biphasic Neutrophil Recovery after CD19 CART in R/R LBCL Is Associated with Superior PFS/OS, Robust CAR T-Cell Expansion in Relation to Baseline Tumor Volume, and a Decrease of Systemic Inflammation over Time (2022) Rejeski K, Perez AP, Iacoboni G, Buecklein VL, Blumenberg V, Völkl S, Penack O, et al. Conference contribution In-depth characterisation of a cohort of individuals with missense and loss-of-function variants disrupting FOXP2 (2022) Morison LD, Meffert E, Stampfer M, Steiner-Wilke I, Vollmer B, Schulze K, Briggs T, et al. Journal article Interprofessional Communication about Complementary and Integrative Health (CIH): Development and Implementation of a Training Program (2022) Behzad A, Stein B, Kaltenbach A, Lohmueller L, Kroeger B, Boltenhagen U, Joos S, et al. Conference contribution Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg Registry (2022) Haist M, Stege H, Lang BM, Tsochataridou A, Salzmann M, Mohr P, Schadendorf D, et al. Journal article